Filana Therapeutics
FLNA
161 hedge funds and large institutions have $411M invested in Filana Therapeutics in 2024 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 51 increasing their positions, 35 reducing their positions, and 18 closing their positions.
150% more capital invested
Capital invested by funds: $165M → $411M (+$247M)
100% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 18
46% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 35
11% more funds holding
Funds holding: 145 → 161 (+16)
1.44% more ownership
Funds ownership: 27.77% → 29.22% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
54% less call options, than puts
Call options by funds: $109M | Put options by funds: $235M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
+$8.64M |
| 2 |
Morgan Stanley
New York
|
+$8.2M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$6.71M |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$3.01M |
| 5 |
Renaissance Technologies
New York
|
+$1.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.69M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$3.13M |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$2.95M |
| 5 |
Jane Street
New York
|
-$995K |
FLNA Hedge Fund Activity: Q3 2024 in Review
161 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2024, worth a combined $411M — up 150% from $165M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new FLNA positions and 18 closed out — a net gain of 18 holders — while 51 added to existing stakes and 35 trimmed.
The largest buyer was Tidal Investments, opening a new position worth an estimated $8.64M. The largest seller was Susquehanna International Group, cutting an estimated $14.5M.
- 161 institutional investors held Filana Therapeutics (FLNA) as of Q3 2024, up from 145 in Q2 2024.
- Funds reported $411M of Filana Therapeutics stock for Q3 2024, up 150% quarter-over-quarter.
- 36 funds opened new Filana Therapeutics positions in Q3 2024 and 18 closed out, a net change of +18 holders.
- The largest Filana Therapeutics buyer in Q3 2024 was Tidal Investments, an estimated $8.64M added.
- The largest Filana Therapeutics seller in Q3 2024 was Susquehanna International Group, an estimated $14.5M sold.
Based on aggregated 13F filings for Q3 2024.